公司简介

Intellia’s people are committed to disrupting and expanding health care by developing new, first-in-class therapies to address genetic diseases. Each of us contributes our skills, experiences, ideas, hopes and passion to create Intellia.

主要成员

Derrick Rossi、Erik Sontheimer、John Leonard、Jennifer A. Doudna、Rachel E. Haurwitz

产品/服务

• 基因合成|编辑

CRISPR/CAS9

Permanent Modifications（Knockout、Repair、Insert），Non-Permanent Modifications（CRISPRi、CRISPRa）

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2014-11	Atlas Venture、Novartis	$15M
Series B	2015-09	OrbiMed	$70M

关联公司